首页/数据集/Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of IDH1 wild-type GBM

Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of IDH1 wild-type GBM

NIAID Data Ecosystem2026-03-13 收录

GBM胶质母细胞瘤

坏死性凋亡相关lncRNA

数据链接：

https://zenodo.org/record/6973635 数据链接链接失效反馈

官方服务：

资源简介：

Original data:Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of IDH1 wild-type GBM.

应用场景：

创建时间：

2022-08-08

消化系统癌症预后预测

坏死性凋亡相关lncRNA

Additional file 6: Table S6. 171 samples of transcriptome data containing EC and normal samples from the TCGA database..

NIAID Data Ecosystem90

Table4_A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma.xlsx

肾透明细胞癌预后模型

坏死性凋亡相关lncRNA

Background: The incidence of clear cell renal cell carcinoma (ccRCC) is high and has increased gradually in recent years. At present, due to the lack of effective prognostic indicators, the prognosis

NIAID Data Ecosystem40

Table4_A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma.XLSX

胃腺癌预后预测

坏死性凋亡相关lncRNA

Background: As a caspase-independent type of cell death, necroptosis plays a significant role in the initiation, and progression of gastric cancer (GC). Numerous studies have confirmed that long non-c

NIAID Data Ecosystem30

Table2_Necroptosis-related lncRNA in lung adenocarcinoma: A comprehensive analysis based on a prognosis model and a competing endogenous RNA network.xlsx

癌症预后模型

坏死性凋亡相关lncRNA

Background: Necroptosis, an innovative type of programmed cell death, involves the formation of necrosomes and eventually mediates necrosis. Multiple lines of evidence suggest that necroptosis plays a

NIAID Data Ecosystem50

Artificial neural network identified a 20-gene panel with promising value in predicting immunotherapy response and survival benefits after anti-PD1/PD-L1 treatment in GBM patients

GBM胶质母细胞瘤

肿瘤生物标志物

Question: Which biomarker can effectively predict the immunotherapy response and prognostic benefits of GBM patients, and how can potential responders to immune checkpoint inhibitors (ICIs) be disc

Figshare2021-02-25 更新40

Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of IDH1 wild-type GBM

资源简介：

相关数据集